Skip to content

Clinical trials

Observational Cognitive Dysfunction trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Phase: Observational Country / region: Germany Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20091
20101
20141
20151
20171
20186
20193
20212
20223
20242
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting7
Unknown status7
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ludwig-Maximilians - University of Munich3
University Hospital Tuebingen3
Universitätsklinikum Hamburg-Eppendorf3
Charite University, Berlin, Germany2
University Medical Center Rostock2
German Center for Neurodegenerative Diseases (DZNE)1
Henrik Bo Wiberg Larsson1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Max-Planck-Institute of Psychiatry1
Otsuka Pharmaceutical Development & Commercialization, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction27
Alzheimer Disease9
Dementia9
Delirium3
Emergence Delirium3
Parkinson Disease3
Confusion2
Memory Disorders2
Stroke2
Amyloid Neuropathies, Familial1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.